Company

Company

A company, abbreviated 'co.', is a legal entity made up of an association of people, be they natural, legal, or a mixture of both, for carrying on a commercial or industrial enterprise.

No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.

No article has been written about this topic yet.
Be the first one to add some text.

Loading AI-assisted edit mode...

Timeline

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
BioSpace
May 29, 2020
BioSpace
Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYLTM) therapeutic platform, today announced positive d
BioSpace
May 29, 2020
BioSpace
Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, today announced the presentation of positive safety and biomarker data at the 2020 American Society of Clinical Oncology Virtual Scientific Program (ASCO20) from its ongoing Phase 1/2 study of GB1275 in patien
May 29, 2020
BioSpace
Medicenna Presents Data on MDNA11, an IL-2 Superkine at ASCO 2020 - read this article along with other careers information, tips and advice on BioSpace
May 29, 2020
BioSpace
IMFINZI plus tremelimumab Demonstrated Promising Clinical Activity and Tolerability in Patients With Advanced Liver Cancer - read this article along with other careers information, tips and advice on BioSpace
BioSpace
May 28, 2020
BioSpace
Pharmaceutical industry leader to join as the Company prepares for the Phase II clinical trial with merimepodib, an orally administered broad-spectrum anti-viral for COVID-19
BioSpace
May 28, 2020
BioSpace
Myriad Genetics, Inc., a global leader in molecular diagnostics and precision medicine, announced the election of Daniel K. Spiegelman, age 61, to its Board of Directors, effective immediately, expanding the Board to nine members.
BioSpace
May 29, 2020
BioSpace
Eyecarrot Innovations Corp (FRA:2EYA:GR] announces the appointment of Dr. Leonard Press to Chief Scientific Officer.
BioSpace
May 29, 2020
BioSpace
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on the development of treatments for addiction, announced the appointment of Dr. Jack Reich to the Board of Directors. The appointment increases the Board to seven members.
BioSpace
May 28, 2020
BioSpace
RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com ), developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other organs and tissues, today announced that it has expanded its engagement with MCRA, the leading U.S. regulatory group for medical devices and biologics, with over 600 client engagements, globally, to continue to advance the Company's FDA program. MCRA will participate in develo
May 28, 2020
BioSpace
Pressure BioSciences Announces Launch of Novel, FDA Registered Immune Booster by Pending Merger Partner Cannaworx, Inc. - read this article along with other careers information, tips and advice on BioSpace
BioSpace
May 28, 2020
BioSpace
VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced the formation of a Commercial Advisory Board consisting of leading experts in public health policy, epidemiology, and vaccine development. The Commercial Advisory Board will work closely with VBI's management team on pre-commercialization and comm
BioSpace
May 28, 2020
BioSpace
AB201 (rNAPc2) is being developed as a potential treatment for COVID Associated Coagulopathy , a condition characterized by abnormal blood clotting in patients with COVID-19 Previous safety data in more than 700 patients through Phase 2 may enable more rapid development ARCA anticipates filing an IND in the third quarter of 2020 and initiating late-stage clinical testing in the second half of this year Prior rNAPc2 results treating Ebola and Marburg viral infections in non-huma
May 28, 2020
WebWire
The Annual General Meeting (AGM) of Nokia Corporation took place at the Company's headquarters in Espoo on May 27, 2020 under special arrangements due to the COVID-19 pandemic. Approximately 43 000 shareholders representing approximately 2 300 million shares and votes were represented at the meeting. The AGM supported all the Board's proposals by at least 86 percent of the votes cast and rejected the shareholder's proposal on an amendment of the Articles of Association. The AGM adopted the...
SI Reporter
May 28, 2020
@bsindia
The company said in the near term, the demand for the Companys product will be impacted which will have some impact on the results of the Company in the short-term.
BioSpace
May 27, 2020
BioSpace
The BRIGHT Trial Achieved Statistically Significant and Clinically Meaningful Improvements from Baseline in All Subscales of the Aberrant Behavior Checklist
BioSpace
May 27, 2020
BioSpace
Achieved 35% objective response rate, including 10% complete response rate, and 80% disease control rate among twenty evaluable patients with ovarian cancer
May 27, 2020
BioSpace
Urovant Sciences Appoints James Hindman to Board of Directors - read this article along with other careers information, tips and advice on BioSpace
BioSpace
May 27, 2020
BioSpace
MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced plans for a clinical study intended to support registration in the U.S. of flotetuzumab, an investigational, bispecific CD123 x CD3 DART® molecule for patients with acute myeloid leukemia (AML) who are refractory to induction therapy. In
BioSpace
May 27, 2020
BioSpace
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical Company focused on oncology, today announced that a paper, entitled 'BL-8040, a CXCR4 Antagonist, in Combination with Pembrolizumab and Chemotherapy for Pancreatic Cancer: The COMBAT Trial,' has been published in the peer-reviewed journal Nature Medicine
BioSpace
May 27, 2020
BioSpace
OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec"), a company developing late-stage intratumoral cancer immunotherapies, today announced Notices of Allowance for three new patent applications covering its interleukin-12 (IL-12) based immunotherapy platform, including its lead product candidate TAVO
SHOW MORE
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.